30-day postoperative outcomes of neonatal versus delayed anoplasty for perineal and vestibular fistulas.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 19 04 2021
accepted: 22 04 2021
pubmed: 31 5 2021
medline: 18 8 2021
entrez: 30 5 2021
Statut: ppublish

Résumé

The purpose of this study was to compare the postoperative outcomes of neonatal versus delayed repair of rectoperineal and rectovestibular fistulae using a multi-center pediatric colorectal specific database. We hypothesized that the incidence of 30-day postoperative complications is not significantly different between these two surgical treatment strategies. We performed a retrospective, observational study of the Pediatric Colorectal and Pelvic Learning Consortium (PCPLC) database. We included any patient from the database that underwent primary surgical repair of a rectoperineal or rectovestibular fistula. Neonatal repair was defined as occurring within 14 days of birth, and delayed repair as occurring after that period. The primary outcome was the occurrence of postoperative complications within 30 days. 164 patients were included in the study (123 rectoperineal, 41 rectovestibular); the majority (81%) were repaired in a delayed fashion. Patients that underwent delayed repair had lower birth weights and were more likely to be female than those that underwent neonatal repair. Wound breakdown/dehiscence was the most common complication in both groups (Delayed 5.3% v. Neonatal, 6.5%). We found no significant difference in the incidence of any postoperative complication between groups (Delayed 6.0 v. Neonatal 6.5%, p = 1.0). We concluded there was no significant difference in the incidence of 30-day postoperative complications for neonatal versus delayed repair of rectoperineal and rectovestibular fistulae, suggesting that both strategies are safe and may have excellent short-term outcomes in appropriately selected patients.

Identifiants

pubmed: 34052003
pii: S0022-3468(21)00362-6
doi: 10.1016/j.jpedsurg.2021.04.023
pii:
doi:

Types de publication

Case Reports Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1454-1458

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Christopher W Marenco (CW)

Department of Surgery, Madigan Army Medical Center, Tacoma, WA, United States. Electronic address: christopher.w.marenco.mil@mail.mil.

Samuel Rice-Townsend (S)

Department of Surgery, Seattle Children's Hospital, Seattle, WA, United States.

Michael Rollins (M)

Department of Surgery, Primary Children's Hospital, Salt Lake City, UT, United States.

Richard J Wood (RJ)

Department of Pediatric Colorectal & Pelvic Reconstructive Surgery, Nationwide Children's Hospital, Columbus, OH, United States.

Casey Calkins (C)

Department of Surgery, Children's Hospital of Wisconsin, Milwaukee, WI, United States.

Caitlin Smith (C)

Department of Surgery, Seattle Children's Hospital, Seattle, WA, United States.

Megan M Durham (MM)

Division of Pediatric Surgery, Emory University School of Medicine and Children's Healthcare of Atlanta, GA, United States.

Rebecca M Rentea (RM)

Department of Pediatric Surgery, Children's Mercy Kansas City, Kansas City, MO, United States.

Matt Ralls (M)

Department of Pediatric Surgery, C.S. Mott Children's Hospital, Ann Arbor, MI, United States.

Kathleen Van Leeuwen (K)

Department of Pediatric Surgery, Phoenix Children's Hospital, Phoenix, AZ, United States.

Ron W Reeder (RW)

Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States.

Jeffrey Avansino (J)

Department of Surgery, Seattle Children's Hospital, Seattle, WA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH